Armstrong, A.W., Lebwohl, M., Warren, R.B., Sofen, H., Imafuku, S. , Ohtsuki, M., Spelman, L. , Passeron, T., Papp, K.A., Kisa, R.M., Berger, V., Vritzali, E., Hoyt, K., Colombo, M.J., Banerjee, S., Strober, B., Thaçi, D. and Blauvelt, A. 2024. Deucravacitinib in Plaque Psoriasis: 3-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s366. DOI:https://doi.org/10.25251/skin.8.supp.366.